BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11807424)

  • 1. Management of erectile dysfunction secondary to treatment for localized prostate cancer.
    Telöken C
    Cancer Control; 2001; 8(6):540-5. PubMed ID: 11807424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference.
    Miller DC; Wei JT; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin PW; Sanda MG
    Urology; 2006 Jul; 68(1):166-71. PubMed ID: 16844457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of treatments for erectile dysfunction among survivors of prostate carcinoma.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Cancer; 2002 Dec; 95(11):2397-407. PubMed ID: 12436448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
    Potosky AL; Legler J; Albertsen PC; Stanford JL; Gilliland FD; Hamilton AS; Eley JW; Stephenson RA; Harlan LC
    J Natl Cancer Inst; 2000 Oct; 92(19):1582-92. PubMed ID: 11018094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current management of erectile dysfunction in prostate cancer survivors.
    Sherer BA; Levine LA
    Curr Opin Urol; 2014 Jul; 24(4):401-6. PubMed ID: 24809413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention and treatment of erectile dysfunction after prostatectomy: An update].
    Xu P; Wang YH
    Zhonghua Nan Ke Xue; 2017 Jul; 23(7):656-662. PubMed ID: 29723462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining sexual outcomes after treatment for localized prostate carcinoma.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of penile rehabilitation after radical prostatectomy.
    Kim JH; Lee SW
    Korean J Urol; 2015 Feb; 56(2):99-108. PubMed ID: 25685296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Updated treatment of erectile dysfunction after prostatectomy].
    Dong Q; Luo DY; Zeng H
    Zhonghua Nan Ke Xue; 2015 Jun; 21(6):483-8. PubMed ID: 26242035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing and managing erectile dysfunction after prostatectomy for prostate cancer.
    Albaugh JA
    Urol Nurs; 2010; 30(3):167-177, 166. PubMed ID: 20648854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study.
    Stephenson RA; Mori M; Hsieh YC; Beer TM; Stanford JL; Gilliland FD; Hoffman RM; Potosky AL
    J Urol; 2005 Aug; 174(2):646-50; discussion 650. PubMed ID: 16006930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary and sexual disorders following localised prostate cancer management].
    Haab F; Beley S; Cornu JN; Culine S; Cussenot O; Hennequin C
    Bull Cancer; 2010 Dec; 97(12):1537-49. PubMed ID: 21220229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional results and treatment of functional dysfunctions after radical prostatectomy].
    Salomon L; Droupy S; Yiou R; Soulié M
    Prog Urol; 2015 Nov; 25(15):1028-66. PubMed ID: 26519966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erectile dysfunction after radical prostatectomy: value of preoperative programming of intracavernous injections].
    Lebret T; Hervé JM; Yonneau L; Colau A; Kassardjian Z; Barré P; Lugagne-Delpon PM; Botto H
    Prog Urol; 1999 Jun; 9(3):483-8. PubMed ID: 10434322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates.
    Polito M; d'Anzeo G; Conti A; Muzzonigro G
    BJU Int; 2012 Dec; 110(11 Pt C):E954-7. PubMed ID: 23078100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erectile dysfunction following radical therapy for prostate cancer.
    Vale J
    Radiother Oncol; 2000 Dec; 57(3):301-5. PubMed ID: 11104890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.